Spectre G et al. |
Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications. |
2011 |
Thromb. Haemost. |
pmid:21800009
|
Hoh CM et al. |
Evaluation of effects of low-dose aspirin administration on urinary thromboxane metabolites in healthy dogs. |
2011 |
Am. J. Vet. Res. |
pmid:21801060
|
Shen L et al. |
In vivo oxidation, platelet activation and simultaneous occurrence of natural immunity in atherosclerosis-prone mice. |
2011 |
Isr. Med. Assoc. J. |
pmid:21845968
|
Hall JA et al. |
Dietary fish oil alters the lysophospholipid metabolomic profile and decreases urinary 11-dehydro thromboxane Bâ‚‚ concentration in healthy Beagles. |
2011 |
Vet. Immunol. Immunopathol. |
pmid:21925741
|
Thomason J et al. |
Platelet cyclooxygenase expression in normal dogs. |
2011 Sep-Oct |
J. Vet. Intern. Med. |
pmid:21985141
|
Wu P et al. |
Purification and characterization of an NAD(+)-dependent dehydrogenase that catalyzes the oxidation of thromboxane B2 at C-11 from porcine liver. Development and application of 11-dehydro-thromboxane B2 radioimmunoassay to enzyme assay. |
1990 |
Biochim. Biophys. Acta |
pmid:2223826
|
Mullins KB et al. |
Effects of carprofen, meloxicam and deracoxib on platelet function in dogs. |
2012 |
Vet Anaesth Analg |
pmid:22248445
|
Lemkes BA et al. |
The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus. |
2012 |
J. Thromb. Haemost. |
pmid:22252020
|
Li C et al. |
Reversal of the anti-platelet effects of aspirin and clopidogrel. |
2012 |
J. Thromb. Haemost. |
pmid:22268852
|
Hartanto MD et al. |
Urinary 11-dehydro-thromboxane Bâ‚‚ and 2,3-dinor-6-keto-prostaglandin-Fâ‚α in healthy post-menopausal and pre-menopausal women receiving aspirin 100 mg. |
2012 |
J. Thromb. Thrombolysis |
pmid:22311294
|
Ciabattoni G et al. |
Radioimmunoassay of 11-dehydrothromboxane B2. |
1990 |
Meth. Enzymol. |
pmid:2233352
|
Cesari M et al. |
Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study. |
2012 |
J. Gerontol. A Biol. Sci. Med. Sci. |
pmid:22389462
|
Vazzana N et al. |
Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress. |
2012 |
J. Clin. Endocrinol. Metab. |
pmid:22761461
|
Dragani A et al. |
Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism. |
2012 |
Thromb. Haemost. |
pmid:22782530
|
Sadilkova L et al. |
The effect of selected pre-analytical phase variables on plasma thromboxane Aâ‚‚ measurements in humans. |
2013 |
Int J Lab Hematol |
pmid:22908995
|
Yi X et al. |
Platelet response to aspirin in Chinese stroke patients is independent of genetic polymorphisms of COX-1 C50T and COX-2 G765C. |
2013 |
J. Atheroscler. Thromb. |
pmid:22972377
|
Gautier-Veyret E et al. |
Intermittent hypoxia-activated cyclooxygenase pathway: role in atherosclerosis. |
2013 |
Eur. Respir. J. |
pmid:23060635
|
Olson MT et al. |
Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk. |
2012 |
J. Thromb. Haemost. |
pmid:23072449
|
Dudley A et al. |
Cyclooxygenase expression and platelet function in healthy dogs receiving low-dose aspirin. |
2013 Jan-Feb |
J. Vet. Intern. Med. |
pmid:23278865
|
Carroll RC et al. |
A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane. |
2013 |
Anesth. Analg. |
pmid:23302970
|
Dharmasaroja PA et al. |
Aspirin nonresponders in patients with ischaemic stroke. |
2013 |
Blood Coagul. Fibrinolysis |
pmid:23429255
|
Davì G et al. |
Thromboxane biosynthesis and platelet function in type II diabetes mellitus. |
1990 |
N. Engl. J. Med. |
pmid:2345567
|
Vazzana N et al. |
Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype. |
2013 |
J Am Heart Assoc |
pmid:23557750
|
Nakamura A et al. |
Oral administration of a novel long-acting prostacyclin agonist with thromboxane synthase inhibitory activity for pulmonary arterial hypertension. |
2013 |
Circ. J. |
pmid:23676973
|
Hayashi Y et al. |
Immunoaffinity purification of 11-dehydro-thromboxane B2 from human urine and plasma for quantitative analysis by radioimmunoassay. |
1990 |
Anal. Biochem. |
pmid:2372112
|
Gremmel T et al. |
Differential impact of inflammation on six laboratory assays measuring residual arachidonic acid-inducible platelet reactivity during dual antiplatelet therapy. |
2013 |
J. Atheroscler. Thromb. |
pmid:23739624
|
DeFilippis AP et al. |
Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction. |
2013 |
Circ. J. |
pmid:23985963
|
d'Emmanuele di Villa Bianca R et al. |
Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24019484
|
Santilli F et al. |
Effects of high-amount-high-intensity exercise on in vivo platelet activation: modulation by lipid peroxidation and AGE/RAGE axis. |
2013 |
Thromb. Haemost. |
pmid:24030807
|
Kapłon-Cieślicka A et al. |
Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes. |
2013 |
Kardiol Pol |
pmid:24065375
|
|
|
|
|
pmid:24126290
|
Gonçalves LH et al. |
Acetylsalicylic acid therapy: influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels. |
2014 |
Clin. Chim. Acta |
pmid:24316050
|
DeFilippis AP et al. |
Fatty acids and TxA(2) generation, in the absence of platelet-COX-1 activity. |
2014 |
Nutr Metab Cardiovasc Dis |
pmid:24370448
|
|
|
|
|
pmid:24763965
|
Ross S et al. |
Association of cyclooxygenase-2 genetic variant with cardiovascular disease. |
2014 |
Eur. Heart J. |
pmid:24796340
|
|
|
|
|
pmid:24803308
|
|
|
|
|
pmid:24907931
|
Santilli F et al. |
Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment. |
2014 |
J Am Heart Assoc |
pmid:25037196
|
Lattanzio S et al. |
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. |
2014 |
J Am Heart Assoc |
pmid:25037197
|
Lupinetti MD et al. |
Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. |
1989 |
Am. Rev. Respir. Dis. |
pmid:2508524
|
Floyd CN et al. |
Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects. |
2014 |
Br J Clin Pharmacol |
pmid:25099258
|
|
|
|
|
pmid:25288566
|
|
|
|
|
pmid:25466142
|
|
|
|
|
pmid:25589198
|
|
|
|
|
pmid:25669623
|
|
|
|
|
pmid:25759102
|
|
|
|
|
pmid:25808116
|
Véricel E et al. |
Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients. |
2015 |
Thromb. Haemost. |
pmid:25832443
|
Lorenz RL et al. |
A critical evaluation of urinary immunoreactive thromboxane: feasibility of its determination as a potential vascular risk indicator. |
1989 |
Biochim. Biophys. Acta |
pmid:2597697
|
|
|
|
|
pmid:26095809
|